676. Adulteration and misbranding of Camphor Liniment, Anthelmintic Tablets,
and Kamala Compound Tio. 1 Tablets; and misbranding of Marnecro Con-
centrate, Marespy Tablets, and Fowl Enteric Tablets. TJ. S. v. Marrinan
Supply Co., Inc. Plea of guilty. Fine, $45. (F. D. C. Nos. 4137 5480.
Sample Nos. 38116-E, 38404-E, 386^7-E, 38659-E, 38?60^E, 38661-E.)
The Camphor L'niment differed from the pharmacopoeial requirements. The
Anthelmintic Tablets and Kamala Compound No. 1 fell below their declared
standards and they and the remaining products bore on their labeling false and
misleading claims regarding their efficacy in the treatment of diseases of animals
and poultry. The Marnecro Concentrate was falsely represented to contain
copper arsenite and its label failed to bear an accurate statement of the quantity
of the contents.
On October 27, 1941, the United States attorney for the District of Minnesota
filed an information against the Marrinan Supply Co., Inc., St. Paul. Minn., al-
leging shipment within the period from on or about September 9 to on or about
October 18,1940, from the State of Minnesota into the States of Wisconsin, Iowa,
North Dakota^ and South Dakota of quantities of the above-named products
which were misbranded and portions of which were also adulterated.
The Camphor Liniment was alleged to be adulterated: (1) In that it pur-
ported to be or was represented as a drug the name of which is recognized in the
United States Pharmacopoeia but its strength differed from or its quality or
purity fell below the standard set forth in such compendium since it contained not
more than 1.7 percent of camphor, and did contain small proportions of ammonium
chloride, ammonia water, and aromatics, whereas the pharmacopoeia provides
that camphor liniment shall contain not less than 19 percent of camphor, and
does not mention ammonium chloride, ammonia water, or aromatics as con-
stituents of camphor liniment; and the difference in strength, quality, or
purity from such standard was not plainly stated on the label. (2) In that a
substance containing not more than 1.7 percent of camphor, small proportions of
ammonium chloride, ammonia water, and aromatics had been substituted wholly
or in part for camphor liniment, which it purported to be. It was alleged to be
misbranded in that the statement "Camphor Liniment," appearing on the label,
was false and misleading.
Analysis of the Marnecro Concentrate showed that it consisted essentially of
charcoal, sulfur, copper sulfate, sodium sulfate, iron sulfate, and sodium chloride,
but no copper arsenite or other arsenic-bearing substances. It was alleged to
be misbranded (1) in that representations in the labeling that it was effica-
cious in the prevention and cure of necrotic enteritis in pigs; and as an antiseptic,
vermifuge, and febrifuge; that it would absorb and hold deleterious gases, increase
gastric juices, aid digestion, eliminate waste from the body, and purify the
blood; and would be efficacious in the treatment of scours, were false and mis-
leading since it would not be efficacious for such purposes; (2) in that the
statement "Copper Arsenite" on the label was false and misleading since it
contained no copper arsenite; and (3) in that it was in package form and its
label did not bear an accurate statement of the quantity of the contents in terms
of weight.
Analysis of the Anthelmintic Tablets showed that they contained not more
than 5.23 grains of kamala and not more than 8.62 grains of copper sulfate per
tablet. They were alleged to be adulterated in that their strength differed from
or their quality or purity fell below that which they purported and were repre-
sented to possess, since each of the tablets purported and was represented to
contain 10 grains of kamala and 10 grains of copper sulfate; whereas the tablets
each contained not more than 5.23 grains of kamala" and not more than 8.62
grains of copper sulfate. They were alleged to be misbranded (1) in that state-
ments in the labeling which represented that they were efficacious as an anthel-
mintic, for the control of "tapeworm infection," to remove stomach worms, and
as a general anthelmintic agent for sheep and goats, were false and misleading
since they were not efficacious for such purposes; and (2) in that the statement
"Each Tablet Contains: Kamala 10 grs. Copper Sulphate 10 grs.," borne on the
box, was false and misleading since the tablets contained less kamala and
copper sulfate than the amounts represented.
Analysis of the Marespy Tablets showed that they consisted essentially of
eucalyptol, small proportions of guaiacol, potassium chlorate, and a chromium
compound, with inert ingredients such as calcium carbonate and magnesium
carbonate. They were alleged to be misbranded in that the statement "Roup"
appearing on the boxes was false and misleading since they were not efficacious in
the treatment of roup in poultry.
Analysis showed that the Kamala Compound No. 1 Tablets contained not
more than 7.12 grains of kamala and not less than 1.20 grains of nicotine sulfate
per tablet. They also contained calomel, a mercurial derivative, in the amount
of approximately ? grain per tablet. They were alleged to be adulterated in
that their strength differed from that which they purported and were repre-
sented to possess since each of the tablets was represented to contain 9 grains
of kamala and ^4 grain of nicotine sulfate; whereas the tablets contained not more
than 7.12 grains of kamala and not less than 1.20 grains of nicotine sulfate.
They were alleged to be misbranded (1) in that the statement in the labeling
which represented that they were efficacious for the treatment of poultry in-
fested with roundworms or tapeworms was false and misleading since they
would not be efficacious for such purposes; (2) in that the statement "Tablets
*    *    *    Kamala 9 grs. Nicotine Sulphate ? gr.," appearing on the boxes, was
false and misleading since the tablets contained not more than 7.12 grains of
kamala and not less than 1.20 grains of nicotine sulfate; and (3) in that they
were fabricated from two or more ingredients and contained the ingredient
calomel, a derivative or preparation of mercury, and the label did not show that
said ingredient was a derivative or preparation of mercury.
Analysis showed that the Fowl Enteric Tablets consisted essentially of com-
pounds of calcium, sodium, and copper, sulfates, phenolsulfates, and approxi-
mately 1/10 grain of copper arsenite per tablet.
They were alleged to be misbranded (1) in that the statements in the labeling
which represented that they were efficacious in the treatment of enteritis, black-
head, and various intestinal infections in fowls were false and misleading since
they were not efficacious for such purposes; and (2) in that they were fabricated
from two or more ingredients and contained arsenic, but the label did not bear
the common or usual name of each active ingredient, including the quantity or
proportion of arsenic that they contained.
On November 12, 1941, a plea of guilty was entered on behalf of the defendant
and a fine of $45 was imposed by the court.